Jilin University , China
Title Of Presentation :
Activin A regulates proliferation and migration of human breast cancer cells
Zhonghui Liu has his expertise in tumor immunity and innate immunity. His study on the tumor biotherapy based on activin signaling transduction reveals new gene targets for tumor therapy. He is the editor-in-Chief of Medical Immunology Technology, a textbook for medical postgraduates in Chinese Universities. So far, more than 50 papers have been published in Journal Cell Science, Journal of Endocrinology, Cellular Molecular Immunology, Open Biology and other academic journals.